Article
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells
3 Aug 2016
Abstract excerpt
OBJECTIVE: Glioblastoma multiforme (GBM) develops from a small subpopulation of stem-like cells, which are endowed with the ability to self-renew, proliferate and give rise to progeny of multiple neuroepithelial lineages. These cells are resistant to conventional chemo- and radiotherapy and are hence also responsible for tumor recurrence. HMGA1 overexpression has been shown to correlate with proliferation,...
Topics
Join the communities discussing this publication.